Covidien plc to Report First-Quarter Results on January 25, 2013

  Covidien plc to Report First-Quarter Results on January 25, 2013

Business Wire

DUBLIN -- December 12, 2012

Covidien plc (NYSE: COV) will report first-quarter results on January 25,
2013, before trading begins. The Company will hold a conference call for
investors at 8:30 a.m. ET. The call can be accessed in the following ways:

  *At Covidien’s website:
  *By telephone: For both “listen-only” participants and those participants
    who wish to take part in the question-and-answer portion of the call, the
    telephone dial-in number in the U.S. is 800-561-2693. For participants
    outside the U.S., the dial-in number is 617-614-3523. The access code for
    all callers is 83035324.
  *Through an audio replay: A replay of the conference call will be available
    beginning at 11:30 a.m. on January 25, 2013, and ending at 5:00 p.m. on
    February 1, 2013. The dial-in number for U.S. participants is
    888-286-8010. For participants outside the U.S., the replay dial-in number
    is 617-801-6888. The replay access code for all callers is 90266221.


Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in three
segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012
revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70
countries, and its products are sold in over 140 countries. Please visit to learn more about our business.


Eric Kraus, 508-261-8305
Senior Vice President
Corporate Communications
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
Bruce Farmer, 508-452-4372
Vice President
Public Relations
Todd Carpenter, 508-452-4363
Investor Relations
Press spacebar to pause and continue. Press esc to stop.